Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use JORNAY PM® safely and effectively. See full prescribing information for JORNAY PM. JORNAY PM (methylphenidate hydrochloride) extended-release capsules, for oral use, CII Initial U.S. Approval: 1955
Medication labelWhy this: Advisory · dailymed-prescription
JORNAY PM is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older [see Clinical Studies (14)].
- generic_name
- methylphenidate hydrochloride
- product_names
- Methylphenidate Hydrochloride
- ndc
- 71376-201, 71376-202, 71376-203, 71376-204, 71376-205, 71376-201-03, 71376-202-03, 71376-203-03, 71376-204-03, 71376-205-03
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en